
IPO on October 4: Novartis confirms Sandoz spin-off date
class=”sc-29f61514-0 icZBHN”> Novartis and Sandoz’s separation is imminent (archive image) Key regulatory approvals,
class=”sc-29f61514-0 icZBHN”> Novartis and Sandoz’s separation is imminent (archive image) Key regulatory approvals,
class=”sc-29f61514-0 icZBHN”> 1/2 Stéphane Bancel, CEO of Moderna. Moderna had the vaccine produced
class=”sc-29f61514-0 icZBHN”> 1/6 There’s a lot at stake for UBS on Wednesday. Christian
class=”sc-29f61514-0 icZBHN”> 1/6 Shameful accident at Zurich Airport. Levin tribe There is a
class=”sc-29f61514-0 icZBHN”> 1/5 Single-family homes are not in high demand anymore. Christian KolbeEconomics
class=”sc-29f61514-0 icZBHN”> 1/5 Finma’s second headquarters is in Zurich. Defeat Schmid* Since the
class=”sc-29f61514-0 icZBHN”> 1/5 Anne-Geneviève Bütikofer sounded the alarm: “If we don’t act now,
class=”sc-29f61514-0 icZBHN”> 1/5 Expensive at first glance, but not so much in international
class=”sc-29f61514-0 icZBHN”> 1/7 Victor von Wartburg has been fighting for public riverside paths
class=”sc-29f61514-0 icZBHN”> 1/5 Similasan CEO Urs Lehmann has little to smile about these